Pharmaceutical

Sanofi invests $1.4bn in insulin production in Germany

Sanofi has announced a significant investment of €1.3bn ($1.4bn) to expand its insulin production capabilities in Frankfurt, Germany.

Aug 3, 2024 - 04:00
Sanofi invests $1.4bn in insulin production in Germany
Sanofi has announced a significant investment of €1.3bn ($1.4bn) to expand its insulin production capabilities in Frankfurt, Germany.
Read the original article

Tags:

Previous Article

Rejuvenate and SAS partner to harness AI for age-related diseases

Next Article

FDA expands GSK’s Jemperli approval for endometrial cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pfizer boasts over 30% increase in Q3 revenues against previous year

Pfizer boasts over 30% increase in Q3 revenues against ...

Nov 1, 2024

Novartis expands Cosentyx reach for rheumatic diseases with IV version approval

Novartis expands Cosentyx reach for rheumatic diseases ...

Oct 9, 2023

Africa: Unleashing the potential of the new superpower in clinical trials

Africa: Unleashing the potential of the new superpower ...

Mar 21, 2023